Texas Rangers: 3 Things to Watch For Against the Red Sox
By Andrew Webb
The bullpen has continued to let down the Rangers, but Rougned Odor is the second biggest disappointment this season. In 2016 Odor hit .271 setting career highs in home runs (33) and RBI (88) but has been horrible in ’17.
Heading into the Boston series Odor is hitting .213 with 14 home runs and 35 RBI and has a team leading 324 at-bats. He’s walked just 13 times with 79 strikeouts, and has been trending the wrong way most of the season.
The Rangers signed Odor to a six-year $49.5 million deal over the off-season. Odor has failed to show he’s even worth half of the money, and could be a potential candidate to be moved later this month.
More from Nolan Writin'
- Framework for a potential Max Fried trade to the Texas Rangers
- Early 2023 MLB mock draft has Texas Rangers selecting an Ohtani-lite
- 3 Texas Rangers outfield trade targets not named Bryan Reynolds
- Did Jacob deGrom really mean what he said at his Texas Rangers press conference?
- Where do Texas Rangers prospects Jack Leiter and Kumar Rocker stand after the DeGrom signing?
It’s unlikely the Rangers move Odor, but they should at least field offers for him. If this trend continues he could see time in Triple-A to get his swing back. This series is important for Odor to gain some confidence.
This series is a huge one for Texas and they desperately need Odor to step up and be a leader on offense. If he continues to struggle through this Boston series he could very well be in the minors before the week is over.